Lamark Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.11 M
- Paid Up Capital ₹ 55.11 K
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 918.63%
- Profit Growth 100.19%
- Ebitda -183.14%
- Net Worth 0.07%
- Total Assets 3.86%
About Lamark Biotech
Lamark Biotech Private Limited (LBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 October 2018 (Six years and three months 1 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.11 M and a paid-up capital of Rs 55.11 K , as per Ministry of Corporate Affairs (MCA) records.
Inderkumar Bhatia, Rajat Bhatia, and Vaibhav Bhatia serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999GJ2018PTC105007
- Company No.
105007
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2018
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Lamark Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaibhav Bhatia  | Director | 15-Oct-2019 | Current |
| Rajat Bhatia | Director | 30-Oct-2018 | Current |
| Inderkumar Bhatia | Director | 30-Oct-2018 | Current |
Financial Performance of Lamark Biotech.
Lamark Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 918.63% increase. The company also saw a substantial improvement in profitability, with a 100.19% increase in profit. The company's net worth moved up by a moderate rise of 0.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lamark Biotech?
In 2021, Lamark Biotech had a public holding of 4.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lamark Biotech?
Unlock and access historical data on people associated with Lamark Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lamark Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lamark Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.